Alliance A022101/NRG-GI009: A pragmatic randomized phase III trial evaluating total ablative therapy for patients with limited metastatic colorectal cancer—Evaluating radiation, ablation, and surgery (ERASur) Meeting Abstract

  

Authors:	Romesser, P. B.; Miller, E. D.; Shi, Q.; Dixon, J. G.; Gholami, S.; White, S. B.; Wu, C.; Goulet, C. C.; Jee, K. W.; Wright, C. L.; Yaeger, R.; Shergill, A.; Hong, T. S.; George, T. J.; O'Reilly, E. M.; Meyerhardt, J. A.; Hitchcock, K.
Abstract Title:	Alliance A022101/NRG-GI009: A pragmatic randomized phase III trial evaluating total ablative therapy for patients with limited metastatic colorectal cancer—Evaluating radiation, ablation, and surgery (ERASur)
Meeting Title:	2025 ASCO Gastrointestinal Cancers Symposium
Journal Title:	Journal of Clinical Oncology
Volume:	43
Issue:	4 Suppl.
Meeting Dates:	2025 Jan 23-25
Meeting Location:	San Francisco, CA
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2025-02-01
DOI:	10.1200/JCO.2025.43.4_suppl.TPS309
PROVIDER:	EBSCOhost
PROVIDER:	cinahl plus with full text
DOI/URL:	https://research.ebsco.com/linkprocessor/plink?id=cd136323-5736-3552-8692-499710cd940c
Notes:	Meeting abstract: TPS309 -- Source: CINAHL Plus with Full Text

https://synapse.mskcc.org/synapse/works/has_related_data_chk/222538